Get the Stockscreener App
0.00
100.00%
-0.8441
Mainz Biomed N V stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
See More
Previous Close:
$0.8441
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$10.56M
Revenue:
$895.50K
Net Income/Loss:
$-26.30M
P/E Ratio:
0.00
EPS:
-65.5728
Net Cash Flow:
$-23.84M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.0999
Mainz Biomed N V Stock (MYNZ) Company Profile
Name
Mainz Biomed N V
Sector
Industry
Phone
-
Address
-
Compare MYNZ vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
0.00 | 10.56M | 895.50K | -26.30M | -23.84M | -65.57 |
TMO
Thermo Fisher Scientific Inc
|
472.49 | 174.74B | 45.20B | 6.88B | 6.75B | 18.19 |
DHR
Danaher Corp
|
175.71 | 126.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
566.95 | 45.14B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.70 | 32.46B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
306.85 | 29.52B | 3.17B | 642.63M | 516.49M | 10.77 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Maxim Group | Buy |
| Nov-25-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-21-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-21-22 | Initiated | H.C. Wainwright | Buy |
Mainz Biomed N V Stock (MYNZ) Latest News
Mainz Biomed changes ticker symbol to QUCY - MSN
QUCY Price History for Mainz Biomed N.V. Stock - Barchart.com
Quantum Cyber N.V. Announces Name Change, Major Investment, and Board Restructuring Following Shareholder Approval - Minichart
Quantum Cyber N.V. (QUCY) director discloses 2,000 Ordinary Shares on Form 3 - Stock Titan
Quantum Cyber N.V. (QUCY) director files Form 3 showing zero share ownership - Stock Titan
Quantum Cyber N.V. completes major financing and governance overhaul - TipRanks
CEO David Lazar expands Quantum Cyber N.V. (NASDAQ: MYNZ) preferred stake - Stock Titan
David Lazar secures control of Mainz Biomed (Nasdaq: MYNZ) with $6M deal - Stock Titan
Quantum Cyber (NASDAQ: MYNZ) outlines change of control and board overhaul - Stock Titan
What will be the closing price of QUCY stocks? - StockInvest.us
Mainz Biomed N.v. Stock Data and SignalsQUCY - StockInvest.us
QUCY Insider Trading (Mainz Biomed N.v. stock) - StockInvest.us
MSN Money - MSN
Mainz Biomed N.V. announced that it has received $6 million in funding - marketscreener.com
QUCY Stock Price, News & Analysis - Stock Titan
Mainz Biomed Sells Next Gen Colorectal Cancer IP to Focus on Pancreatic Cancer and Post-Quantum Cybersecurity 7 - Minichart
Mainz Biomed NVenters asset purchase agreement on April 9, 2026 for next gen IP saleSEC filing - marketscreener.com
Mainz Biomed (NASDAQ: MYNZ) sells cancer IP and lifts equity above Nasdaq minimum - Stock Titan
An undisclosed buyer entered into a definitive agreement to acquire Next Gen IP of Mainz Biomed N.V. for ?1.2 million. - marketscreener.com
QUCY|Mainz Biomed N V Ord Shs|Price:0.502|Chg%:-0.04 - TradingKey
TradingKey - TradingKey
QUCY|Mainz Biomed N V Ord Shs|Price:0.508|Chg%:-0.00 - TradingKey
Fundamentals Check: Is Mainz Biomed NV a defensive stockQuarterly Earnings Report & Proven Capital Preservation Methods - baoquankhu1.vn
Purchase/sale of business (net) of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Aug Retail: Whats the beta of Mainz Biomed NV stockTrade Performance Summary & Growth Focused Entry Reports - baoquankhu1.vn
Why Is Mainz Biomed N.V. (QUCY) Stock Up Today? - Meyka
QUCY: Mainz Biomed NVComparative Chart - Zacks Investment Research
Mainz Biomed 10-K: Revenue $0.537M, EPS $(2.70) - TradingView
Mainz Biomed N.V. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Mainz Biomed (NASDAQ: QUCY) takes $16.2M loss and plans major Lazar-led recapitalization - Stock Titan
Mainz Biomed NV expected to post a loss of $2.80 a shareEarnings Preview - TradingView
Update Recap: Whats the beta of Mainz Biomed NV stock2026 Volume Leaders & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Smart Money: Whats the beta of Mainz Biomed NV stock2026 AllTime Highs & Breakout Confirmation Trade Signals - baoquankhu1.vn
Mainz Biomed N.V. Receives Nasdaq Notice for Non-Compliance with Minimum Bid Price Rule - Minichart
Mainz Biomed Receives Nasdaq Notice on Bid Price - TipRanks
Mainz Biomed NV (QUCY) Gross Margin (TTM) - zacks.com
Lazar financing could give Mainz Biomed (NASDAQ: MYNZ) 95%+ stake and new direction - Stock Titan
Mainz Biomed Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns Mainz Biomed (MYNZ) over sub-$1.00 bid and possible delisting risk - Stock Titan
Growth Recap: How much upside does Mainz Biomed NV have2026 Major Catalysts & Weekly Momentum Picks - baoquankhu1.vn
Mainz Biomed N.V. (QUCY) Fundamental Analysis - Meyka
Why Is Mainz Biomed N.V. (QUCY) Stock Down Today? - Meyka
Top Mainz Biomed (QUCY) Competitors 2026 - MarketBeat
Block Trades: Can Mainz Biomed NV be recession proofMarket Trend Review & Short-Term High Return Strategies - baoquankhu1.vn
Trend Review: How does Mainz Biomed NV compare to its peersGold Moves & Low Risk Growth Stock Ideas - baoquankhu1.vn
QUCY Technical Analysis & Stock Price Forecast - Intellectia AI
QUCY Stock Price, Quote & Chart | MAINZ BIOMED NV (NASDAQ:QUCY) - ChartMill
QUCY Technical Analysis | Trend, Signals & Chart Patterns | MAINZ BIOMED NV (NASDAQ:QUCY) - ChartMill
Mainz Biomed (QUCY) Stock Chart and Price History 2026 - MarketBeat
Mainz Biomed (QUCY) Stock Forecast and Price Target 2026 - MarketBeat
Total cash dividends paid of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Mainz Biomed N V Stock (MYNZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):